Early Warning of Delayed Cerebral Ischemia

Launched by VILNIUS UNIVERSITY · Aug 17, 2023

Keywords

ClinConnect Summary

This clinical trial is looking to understand how to better predict the health outcomes of patients who have experienced a type of brain bleed known as subarachnoid hemorrhage (SAH). Researchers will analyze various medical tests, such as CT scans and Doppler examinations, to identify specific markers that could indicate the risk of complications like cerebral vasospasms (narrowing of blood vessels in the brain) and delayed cerebral ischemia (a lack of blood flow to the brain). The goal is to find out what information can help doctors anticipate these issues early on, which could improve patient care.

To participate in this study, individuals must be adults who have had a subarachnoid hemorrhage and need surgery for it. Those with mental disorders, minors, and certain other groups (like healthcare workers involved in the trial) cannot take part. If someone is eligible, they can expect to contribute to important research that may help improve understanding and treatment for future patients with similar conditions. This study is currently recruiting participants.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Subarachnoid hemorrhage patients who require SAH surgery and post-operative routine treatment.
• Exclusion Criteria:
• • persons with mental disorders, but who can give consent to participate in biomedical research;
• • minors;
• • students, if their participation in biomedical research is related to studies;
• • persons living in care institutions;
• • soldiers during their actual military service;
• • employees of health care institutions where biomedical research is conducted, subordinate to the researcher;